Parabilis Medicines Inc.
PBLS | NASDAQ
$28.32
-$0.38 (-1.32%)
At close: Oct 30, 2026, 4:00 PM ET
$28.16
-$0.16 (-0.56%)
Pre-market:
Nov 2, 2026, 9:16 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|
Revenue | 148K | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 618K | n/a |
Gross Profit | 148K | n/a | -618K | n/a |
Operating Income | -50.89M | -47.45M | -36.52M | -40.24M |
Interest Income | 4.19M | 2.43M | 1.05M | 1.26M |
Pretax Income | -52.46M | -45.32M | -34.81M | -38.33M |
Net Income | -52.46M | -45.32M | -34.81M | -38.33M |
Selling & General & Admin | 11.66M | 9.7M | 5.78M | 6.34M |
Research & Development | 39.38M | 37.75M | 30.13M | 33.91M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 51.03M | 47.45M | 35.9M | 40.24M |
Interest Expense | 210K | 292K | 396K | 399K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 51.03M | 47.45M | 36.52M | 40.24M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 28.91M | 2.05M | 2.02M | 2.02M |
Shares Outstanding (Diluted) | 28.91M | 2.05M | 2.02M | 2.02M |
EPS (Basic) | -2.32 | -34.58 | -0.36 | -23.84 |
EPS (Diluted) | -2.32 | -34.58 | -0.36 | -23.84 |
EBITDA | -51.66M | -44.42M | -35.9M | -37.27M |
EBIT | -52.25M | -45.02M | -36.52M | -37.93M |
Depreciation & Amortization | 593K | 606K | 618K | 654K |
Add to Watchlist
Select watchlists to add or remove PBLS